7 Stocks Still Trading Below COVID Lows 5 Years Later
Fortunately, the S&P 500 recovered to new all-time highs by August 2020 and is now up about 150% from its COVID lows.
Le Lézard17h
SineuGene Therapeutics Announces FDA IND Clearance for SNUG01, a First-in-Class TRIM72-Targeted Gene Therapy for ALS
SineuGene Therapeutics Co., Ltd. ("SineuGene"), a clinical-stage biotech company pioneering innovative therapies for neurological disorders, today announced that the U.S. Food and Drug Administration ...
Frontiers21h
New Insights into Inflammation Driven Autoimmune Skin Disorders: Trends and Challenges
In the realm of dermatology, inflammatory skin disorders encompass a wide array of skin related serious conditions such as systemic lupus erythematosus, ...
High‑dose vitamin D significantly reduces disease activity in early multiple sclerosis onset, clinical trial finds
Researchers from CHU Nîmes, Université Montpellier, and multiple MS centers in France have found that oral cholecalciferol in ...
Cuproptosis, a form of cell death, may link copper imbalance and atherosclerosis
Atherosclerosis (AS) is a chronic inflammatory disease characterized by the buildup of lipids and immune cells in arterial ...
European Medical Journal22h
Nintedanib May Slow Lung Function Decline in SSc-ILD
Discover how nintedanib effectively slows lung function decline in systemic sclerosis-associated interstitial lung disease, ...
Medscape17h
Belimumab Shows Efficacy for Mucocutaneous Symptoms in SLE
Belimumab plus standard therapy effectively improves mucocutaneous SLE symptoms compared with placebo plus standard therapy, especially in patients with high disease activity and serological activity.